Manu Ohri Gt Biopharma, Inc. (GTBP) insider trading activity

GTBP Quotes by TradingView

Manu Ohri is CFO & Secretary of GT Biopharma, Inc.. Currently has a direct ownership of 0 shares of GTBP, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2023, when has been sold 200,000 shares (Common Stock) at a price of $0.29 per share, resulting in proceeds of $57,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Manu Ohri Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2023
SELL
Other acquisition or disposition
$57,999 $0.29 p/Share
200,000 Reduced 100.0%
0 Common Stock
Aug 11 2023
BUY
Grant, award, or other acquisition
$57,999 $0.29 p/Share
200,000 Added 50.0%
200,000 Common Stock
Jul 15 2022
SELL
Other acquisition or disposition
-
100,000 Reduced 100.0%
0 Common Stock
Jul 15 2022
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock

Also insider at

RVIV
Reviv3 Procare Co Consumer Defensive
Director
MO

Manu Ohri

CFO & Secretary
Brisbane, CA

Track Institutional and Insider Activities on GTBP

Follow GT Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTBP shares.

Notify only if

Insider Trading

Get notified when an Gt Biopharma, Inc. insider buys or sells GTBP shares.

Notify only if

News

Receive news related to GT Biopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GTBP